These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15648965)

  • 21. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
    Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
    Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stroke and cornea verticillata revealing Fabry's disease in a female].
    Fetter D; Bagan-Triquenot A; Guegan-Massardier E; Guyant-Marechal L; Tollard E; Bekri S; Hannequin D
    Rev Neurol (Paris); 2012 Feb; 168(2):181-6. PubMed ID: 22033111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unusual cause of dyspnea.
    Jamali AH; Ahmed RM; Stein H
    Cardiol Rev; 2004; 12(1):10-4. PubMed ID: 14667257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).
    Beer G; Reinecke P; Gabbert HE; Hort W; Kuhn H
    Z Kardiol; 2002 Dec; 91(12):992-1002. PubMed ID: 12490989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fabry's disease with isolated disease of the cardiac muscle, manifesting as hypertrophic cardiomyopathy].
    Elleder M; Dorazilová V; Bradová V; Bĕlohlávek M; Král V; Choura M; Budĕsínský M; Harzer K
    Cas Lek Cesk; 1990 Mar; 129(12):369-72. PubMed ID: 2111224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fabry's disease.
    El-Abassi R; Singhal D; England JD
    J Neurol Sci; 2014 Sep; 344(1-2):5-19. PubMed ID: 25106696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fabry's disease and hypoparathyroidism].
    Misery L; Gregoire M; Prieur F; Froissart R; Guffon N; Maitre S; Fond L; Denis L; Perrot JL; Cambazard F
    Ann Med Interne (Paris); 2002 Jun; 153(4):283-5. PubMed ID: 12218896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal involvement in Anderson-Fabry disease.
    Sessa A; Meroni M; Battini G; Righetti M; Maglio A; Tosoni A; Nebuloni M; Vago G; Giordano F
    J Nephrol; 2003; 16(2):310-3. PubMed ID: 12774774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fabry's disease associated with rheumatoid arthritis. Multisystemic crossroads].
    Arias Martínez N; Barbado Hernández FJ; Pérez Martín G; Pérez de Ayala C; Casal Esteban V; Vázquez Rodríguez JJ
    An Med Interna; 2003 Jan; 20(1):28-30. PubMed ID: 12666306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrioventricular conduction disturbances in a young patient with Fabry's disease without other signs of cardiac involvement.
    Kouris NT; Kontogianni DD; Pavlou MT; Babalis DK
    Int J Cardiol; 2005 Mar; 99(2):327-8. PubMed ID: 15749195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiopulmonary involvement in Fabry's disease.
    Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
    Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myocardial disease in inherited disease].
    Nakao S
    Nihon Rinsho; 2000 Jan; 58(1):200-3. PubMed ID: 10885314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When should cardiologists suspect Anderson-Fabry disease?
    Gambarin FI; Disabella E; Narula J; Diegoli M; Grasso M; Serio A; Favalli BM; Agozzino M; Tavazzi L; Fraser AG; Arbustini E
    Am J Cardiol; 2010 Nov; 106(10):1492-9. PubMed ID: 21059442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CNS manifestations of Fabry's disease.
    Fellgiebel A; Müller MJ; Ginsberg L
    Lancet Neurol; 2006 Sep; 5(9):791-5. PubMed ID: 16914407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The heart in Anderson Fabry disease.
    Kampmann C; Wiethoff CM; Perrot A; Beck M; Dietz R; Osterziel KJ
    Z Kardiol; 2002 Oct; 91(10):786-95. PubMed ID: 12395219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
    Mahmud HM
    J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subclinical Fabry's disease occurring in the context of IgA nephropathy.
    Kawamura O; Sakuraba H; Itoh K; Suzuki Y; Doi M; Kuwabara H; Oshima S; Abe S; Warabi H; Yoshizawa N
    Clin Nephrol; 1997 Feb; 47(2):71-5. PubMed ID: 9049452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac variant of Fabry's disease mimicking hypertrophic cardiomyopathy.
    Chimenti C; Ricci R; Pieroni M; Natale L; Russo MA; Frustaci A
    Cardiologia; 1999 May; 44(5):469-73. PubMed ID: 10389354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.